206 related articles for article (PubMed ID: 25921105)
21. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.
Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW
Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101
[TBL] [Abstract][Full Text] [Related]
22. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer.
Fernández-Fernández L; Tejero E; Tieso A; Rabadán L; Munoz M; Santos I
Int Surg; 1996; 81(4):400-2. PubMed ID: 9127805
[TBL] [Abstract][Full Text] [Related]
23. Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.
Chen XZ; Zhang WH; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Tumour Biol; 2014 Sep; 35(9):9015-22. PubMed ID: 24906604
[TBL] [Abstract][Full Text] [Related]
24. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer.
Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C
Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614
[TBL] [Abstract][Full Text] [Related]
25. The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy.
Strimpakos AS; Cunningham D; Mikropoulos C; Petkar I; Barbachano Y; Chau I
Ann Oncol; 2010 May; 21(5):1013-9. PubMed ID: 19861580
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer.
Kim HJ; Lee KW; Kim YJ; Oh DY; Kim JH; Im SA; Lee JS
Acta Oncol; 2009; 48(3):385-90. PubMed ID: 18855156
[TBL] [Abstract][Full Text] [Related]
30. Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach.
Kim YH; Ajani JA; Ota DM; Lynch P; Roth JA
Cancer; 1995 Jan; 75(2):451-6. PubMed ID: 7812915
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
Gaspar MJ; Arribas I; Coca MC; Díez-Alonso M
Tumour Biol; 2001; 22(5):318-22. PubMed ID: 11553862
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of tumor markers in T4a gastric cancer.
Liu X; Cai H; Wang Y
World J Surg Oncol; 2012 Apr; 10():68. PubMed ID: 22540862
[TBL] [Abstract][Full Text] [Related]
33. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy.
Chen S; Feng XY; Li YF; Zhao BW; Zhou ZW; Chen YB
J Surg Oncol; 2013 May; 107(6):641-5. PubMed ID: 23297055
[TBL] [Abstract][Full Text] [Related]
34. Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer.
Yamao T; Kai S; Kazami A; Koizumi K; Handa T; Takemoto N; Maruyama M
Jpn J Clin Oncol; 1999 Nov; 29(11):550-5. PubMed ID: 10678558
[TBL] [Abstract][Full Text] [Related]
35. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
36. Use of serum and peritoneal CEA and CA19-9 in prediction of peritoneal dissemination and survival of gastric adenocarcinoma patients: are they prognostic factors?
Hasbahceci M; Malya FU; Kunduz E; Guzel M; Unver N; Akcakaya A
Ann R Coll Surg Engl; 2018 Apr; 100(4):257-266. PubMed ID: 29543051
[TBL] [Abstract][Full Text] [Related]
37. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer.
Tachibana M; Takemoto Y; Nakashima Y; Kinugasa S; Kotoh T; Dhar DK; Kohno H; Nagasue N
J Am Coll Surg; 1998 Jul; 187(1):64-8. PubMed ID: 9660027
[TBL] [Abstract][Full Text] [Related]
38. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
39. The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEA.
Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Huang W; Xu K
Mol Biotechnol; 2012 Sep; 52(1):59-67. PubMed ID: 22382453
[TBL] [Abstract][Full Text] [Related]
40. [Correlation between Serum Tumor Markers and Efficacy of First-line EGFR-TKIs in Patients with Advanced Lung Adenocarcinoma].
Chen H; Yang X; Liu H; Ma K; Zhong J; Dong Z; Zhuo M; Wang Y; Li J; An T; Wu M; Wang Z; Zhao J
Zhongguo Fei Ai Za Zhi; 2017 Sep; 20(9):589-597. PubMed ID: 28935011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
